NextCell Pharma AB (STO:NXTCL)
1.180
+0.020 (1.72%)
Apr 29, 2026, 11:25 AM CET
NextCell Pharma AB Market Cap
NextCell Pharma AB has a market cap or net worth of 129.22 million as of April 29, 2026. Its market cap has decreased by -43.97% in one year.
Market Cap
129.22M
Enterprise Value
103.18M
Revenue
9.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.18
Market Cap Chart
Since July 13, 2017, NextCell Pharma AB's market cap has increased from 33.03M to 129.22M, an increase of 291.26%. That is a compound annual growth rate of 16.78%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IRLAB Therapeutics AB | 122.99M |
| Alligator Bioscience AB | 151.06M |
| Annexin Pharmaceuticals AB | 112.24M |
| Elicera Therapeutics AB | 156.04M |
| Simris Group AB (PUBL) | 107.44M |
| AlzeCure Pharma AB | 160.88M |
| Diamyd Medical AB | 165.83M |
| Scandinavian ChemoTech AB | 99.02M |